Oral cobalamin (vitamin B12) treatment. An update

E. Andrès*, N. Dali-Youcef, T. Vogel, K. Serraj, J. Zimmer

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    33 Citations (Scopus)

    Abstract

    The objective of this review was to evaluate oral cobalamin (vitamin B 12) therapy in adult and elderly patients, from the perspective of a hematologist. PubMed was systematically searched for English and French articles published from January 1990 to January 2007. Data from our working group, the 'Groupe d'étude des carences en vitamine B12des Hôpitaux Universitaires de Strasbourg', have also been included. Several prospective studies in well-determined population (n = 4), prospective randomized studies (n = 3) and a systematic review by the Cochrane group (n = 1) provide evidence that oral cobalamin therapy may adequately treat cobalamin deficiency, particularly hematological abnormalities or manifestations. These studies suggest that at least 1000 μg/day of oral cyanocobalmin are needed for pernicious anemia and a mean daily dose of 250 μg for food-cobalamin malabsorption. This present review confirms the previously reported efficacy of oral cobalamin treatment in adult and elderly patients.

    Original languageEnglish
    Pages (from-to)1-8
    Number of pages8
    JournalInternational Journal of Laboratory Hematology
    Volume31
    Issue number1
    DOIs
    Publication statusPublished - Feb 2009

    Keywords

    • Cobalamin
    • Food-cobalamin therapy
    • Pernicious anemia
    • Treatment
    • Vitamin B

    Fingerprint

    Dive into the research topics of 'Oral cobalamin (vitamin B12) treatment. An update'. Together they form a unique fingerprint.

    Cite this